
With over 25 years of executive leadership across the pharmaceutical, biotech, diagnostics, and PBM industries, Denise brings unparalleled expertise and vision to RxDNA’s mission of smarter, more transparent pharmacy benefit management. She has held senior roles with leading organizations like Merck and ProAct, and has been instrumental i
With over 25 years of executive leadership across the pharmaceutical, biotech, diagnostics, and PBM industries, Denise brings unparalleled expertise and vision to RxDNA’s mission of smarter, more transparent pharmacy benefit management. She has held senior roles with leading organizations like Merck and ProAct, and has been instrumental in driving innovation across pharmacogenomics, cancer diagnostics, molecular testing, and regenerative medicine.
Denise’s career is built on results and relentless innovation launching nationally recognized therapies and diagnostics, while pioneering regenerative wellness programs such as MSC stem cell treatments for patients with chronic and autoimmune conditions. At RxDNA, she leads strategic broker and consultant engagement, empowering self-funded employer groups to expose hidden costs, manage specialty drug challenges, and adopt benefit strategies grounded in clinical and financial integrity.
Her leadership style blends clinical acumen with strong industry relationships and future-focused thinking. Denise is known for her friendly but persistent engagement to deliver a client-first approach and her commitment to delivering actionable, real-time insights through RxDNA’s rapid RFP platform.
Outside of work, Denise enjoys her family and dear friends while traveling, playing tennis, cooking, gardening, volunteering, and discovering new local gems.